<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">JCNR</journal-id><journal-title-group><journal-title>Journal of Clinical and Nursing Research</journal-title></journal-title-group><issn>2208-3685</issn><eissn>2208-3693</eissn><publisher><publisher-name>Bio-Byword Scientific Publishing Pty. Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.26689/jcnr.v8i6.6630</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>A Study on the Association Between Siglec-1 Gene Polymorphism and Susceptibility in Patients with Chronic Obstructive Pulmonary Disease in Luohe Area</title><url>https://artdesignp.com/journal/JCNR/8/6/10.26689/jcnr.v8i6.6630</url><author>CaoJuan,WangChun'e,ZhaoBing,ZhengYi,LiSensen</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>8</volume><issue>6</issue><history><date date-type="pub"><published-time>2024-06-10</published-time></date></history><abstract>Objective: To analyze the association between Siglec-1 gene polymorphism and susceptibility to chronic obstructive pulmonary disease (COPD) in the population of the Luohe area. Methods: A case-control study (150 COPD patients and 150 healthy controls) was conducted to analyze the Siglec-1 allele in two groups of individuals using single nucleotide polymorphism (SNP) high-throughput detection technology, and the frequencies of each allele were compared. Results: The frequency of rs611847 heterozygous A/G genotype in COPD patients was significantly lower in females than in healthy controls (OR = 0.282, 95% CI = 0.085–0.938, P = 0.039); among smokers, the frequency of rs3859664 and rs6084444 genotypes in COPD patients was significantly higher than that in the healthy control group (OR = 2.028, 95% CI = 1.111–3.704, P = 0.021; OR = 1.836, 95% CI = 1.033–3.262, P = 0.038). Conclusion: Among the COPD population in the Luohe area, there is a significant correlation between the genotypes of three SNPs loci, rs3859664, rs6084444, and rs611847 and susceptibility to COPD in different subgroups of the population. The rs3859664 A/G-A/A and rs6084444 A/G-G/G genotypes can increase the risk of COPD in smokers; the rs611847 heterozygous A/G genotype can reduce the risk of COPD in both female and smoking populations.</abstract><keywords/></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>Wang C, Xu J, Yang L, et al., 2018, Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. Lancet, 391: 1706–1717.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><p>Stockley AR, 2009, Progression of Chronic Objective Pulmonary Disease: Impact of Inflation, Complications, and Thermal Intervention. Current Medical Research &amp; Opinion, 25(5): 1235–1245.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><p>Willemse BW, Postma DS, Timens W, et al., 2004, The Impact of Smoking Cessation on Respiratory Symptoms, Lung Function, Airway Hyperresponsiveness and Inflammation. Eur Respir J, (23): 464–476.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><p>Bochner BS, Zimmermann N, 2015, Role of Singles and Related Glycan Binding Proteins in Immune Responses and Immune Regulation. Journal of Allergy and Clinical Immunology, 135(3): 598–608.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><p>Siddiqui SS, Matar R, Merheb M, et al., 2019, Siglecs in Brain Function and Neurological Disorders. Cells, 8(10): 1125.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><p>de Lima DS, Nunes VCL, Ogusku MM, et al., 2017, Polymorphisms in SIGLEC1 Contribute to Susceptibility to Primary Active Tuberosity Likely Through the Regulation of IL-1ß. Infect Genet Evol, (55): 313–317.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><p>Chen Y, 2019, Interpretation of Global Strategies for Diagnosis, Treatment, and Prevention of Chronic Obstructive Pulmonary Disease by GOLD in 2020. Chinese Journal of Medical Frontiers (Electronic Edition), 11(12): 32–50.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><p>Wang Z, Bian T, Wu Y, 2023, Research Progress on the Relationship Between Immune Metabolism of Alveolar Macrophages and Chronic Obstructive Pulmonary Disease. Chinese Journal of Immunology, 39(10): 2076–2080.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><p>Li R, Xiao L, 2023, Research Progress on Immune Cells and Factors Related to Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of PLA Medicine, 48(11): 1353–1358.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><p>Landig CS, Hazel A, Kellman BP, et al., 2019, Evolution of the Exclusively Human Pathogen Neisseria gonorrhoeae: Human-Specific Engagement of Immunoregulatory Siglecs. Evol Appl, 12(2): 337–349.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><p>Li S, Jiang L, Yang Y, et al., 2020, Siglec1 Enhances Inflammation Through miR-1260 Dependent Degradation of I?B? in COPD. Exp Mol Pathol, (113): 104398.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><p>Li S, Jiang L, Yang Y, et al., 2020, MiR-195-5p Inhibit the Development of Chronic Objective Pulmonary Disease Via Targeting Siglec1. Hum Exp Toxicol, (39): 1333–1344.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><p>Li K, Li X, Cong Z, et al., 2017, Research Progress on the Role of Siglec-1 in Diseases. Chinese Journal of Comparative Medicine, 27(12): 109–114.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><p>Chen P, Kong M, Yu S, et al., 2016, The Expression of Siglec-1 in Peripheral Blood Monocytes of Patients with Ulcerative Colitis. Journal of Gastroenterology and Hepatology, 25(07): 749–751.</p><pub-id pub-id-type="doi"/></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><p>Cui X, Li Y, 2023, Research Progress on the Relationship Between Sialic Acid Adhesin and Kidney Disease. Journal of Clinical Kidney Disease, 23(07): 594–598.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
